Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

G1 THERAP

  • FDA Approval
  • April 06, 2023, 18:18 UTC
  • 27
  • 0 comments

FDA approve TRILACICLIB DIHYDROCHLORIDE

Comment Full text

GUERBET

  • FDA Approval
  • April 06, 2023, 18:18 UTC
  • 31
  • 0 comments

FDA approve ETHIODIZED OIL

Comment Full text

BIONPHARMA INC

  • FDA Approval
  • April 06, 2023, 11:38 UTC
  • 33
  • 0 comments

FDA approve PROCHLORPERAZINE MALEATE

Comment Full text

AMNEAL

  • FDA Approval
  • April 06, 2023, 11:38 UTC
  • 32
  • 0 comments

FDA approve NELARABINE

Comment Full text

ZYDUS

  • FDA Approval
  • April 06, 2023, 11:38 UTC
  • 30
  • 0 comments

FDA approve ACETAZOLAMIDE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • April 06, 2023, 11:38 UTC
  • 27
  • 0 comments

FDA approve CARBIDOPA; LEVODOPA

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • April 06, 2023, 11:38 UTC
  • 28
  • 0 comments

FDA approve SIROLIMUS

Comment Full text

MYLAN

  • FDA Approval
  • April 06, 2023, 11:38 UTC
  • 28
  • 0 comments

FDA approve REGADENOSON

Comment Full text

JAZZ

  • FDA Approval
  • April 06, 2023, 11:38 UTC
  • 29
  • 0 comments

FDA approve CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • April 06, 2023, 11:38 UTC
  • 29
  • 0 comments

FDA approve ROFLUMILAST

Comment Full text
  • Previous
  • 846
  • 847
  • 848
  • 849
  • 850
  • Next

Search

News categories

  • Technical Exchange News(12137)
  • Event(5779)
  • SEC News(257801)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152374)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin